A 32-year-old woman with a history of pelvic inflammatory disease presents with 8 weeks of amenorrhea and right-sided abdominal pain. Transvaginal ultrasound reveals a 2.8 cm gestational sac with a yolk sac in the right fallopian tube. β-hCG is 3,200 mIU/mL. She is hemodynamically stable. Which drug is the first-line pharmacologic treatment for this tubal ectopic pregnancy?

Explanation

## First-Line Medical Management of Tubal Ectopic Pregnancy **Key Point:** Methotrexate remains the gold-standard first-line drug for medical management of hemodynamically stable, unruptured tubal ectopic pregnancy, regardless of location within the tube (ampullary, isthmic, or interstitial). ### Why Methotrexate for Tubal Ectopic? Methotrexate works by: 1. Inhibiting dihydrofolate reductase → blocking DNA synthesis 2. Arresting mitosis in rapidly dividing trophoblastic cells 3. Causing regression and resorption of the ectopic gestation 4. Does NOT depend on tube location or anatomy ### Dosing Strategy for This Patient With β-hCG of 3,200 mIU/mL and ectopic mass 2.8 cm, **two-dose methotrexate** is appropriate: | Parameter | Value | Implication | |-----------|-------|-------------| | β-hCG | 3,200 mIU/mL | Intermediate level → two-dose regimen | | Ectopic mass | 2.8 cm | <3.5 cm → suitable for medical management | | Hemodynamic status | Stable | No rupture → medical management eligible | | Fetal cardiac activity | Not mentioned | Assumed absent (required for medical management) | **Two-dose regimen:** 50 mg/m² IM on days 0 and 4; check β-hCG on days 4 and 7 (expect ≥15% decline between days 4–7). **High-Yield:** Success rate for two-dose methotrexate in β-hCG 1,000–5,000 range is **80–90%**. ### Tubal Location Does NOT Affect Drug Choice - **Ampullary ectopic** (most common, 70%): Methotrexate effective - **Isthmic ectopic** (12%): Methotrexate effective - **Interstitial ectopic** (2–3%, highest rupture risk): Methotrexate still first-line if stable and β-hCG appropriate **Clinical Pearl:** Interstitial ectopic pregnancies have higher rupture risk due to rich vascular supply of the cornua, but medical management with methotrexate is still preferred over surgery if hemodynamically stable and β-hCG <5,000. ### Monitoring Protocol - Baseline: CBC, liver function, renal function, β-hCG - Day 4: β-hCG (expect decline of ≥15% from baseline) - Day 7: β-hCG (expect further decline of ≥15% from day 4) - Weekly β-hCG until undetectable (typically 4–6 weeks) - Pelvic ultrasound at 2 weeks to confirm regression **Warning:** Do NOT use methotrexate if patient has: - Immunodeficiency (including HIV with CD4 <50) - Active pulmonary disease - Peptic ulcer disease - Hematologic abnormality (WBC <3,500, platelets <100,000) - Renal impairment (creatinine >1.4 mg/dL) - Hepatic impairment (AST >40 U/L) ### Why Not Other Options? - **Doxycycline** (antibiotic): Used for treatment of PID (which caused this ectopic), but has NO role in managing established ectopic pregnancy - **Leuprolide** (GnRH agonist): Used for endometriosis and fibroids, NOT for ectopic pregnancy - **Danazol** (androgenic steroid): Used for endometriosis, NOT for ectopic pregnancy [cite:Telinde's Operative Gynecology 13e Ch 12; ACOG Practice Bulletin 193]